What are the symptoms of Drug-Induced Lupus (DIL) syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Lupus-like syndrome presents with symptoms similar to systemic lupus erythematosus (SLE), including joint pain, skin rashes, fever, fatigue, and general malaise, and can be managed by removing the underlying cause and using anti-inflammatory medications like NSAIDs, antimalarials, or corticosteroids, as recommended by the 2019 EULAR guidelines 1.

Symptoms of Lupus-like Syndrome

The symptoms of lupus-like syndrome can vary but often include:

  • Joint pain and swelling
  • Skin rashes, particularly a butterfly-shaped rash across the cheeks and nose
  • Unexplained fever
  • Fatigue and general malaise
  • Photosensitivity
  • Hair loss
  • Mouth sores
  • Raynaud's phenomenon, where fingers turn white or blue in cold temperatures More severe manifestations can include:
  • Chest pain
  • Shortness of breath
  • Kidney problems
  • Neurological symptoms like headaches, confusion, or seizures

Diagnosis and Treatment

Blood tests often show positive antinuclear antibodies (ANA) but may lack other specific lupus markers. If medication-induced, symptoms typically improve after discontinuing the triggering drug, which may include hydralazine, procainamide, isoniazid, minocycline, or certain anti-seizure medications. Treatment focuses on removing the underlying cause and managing symptoms with anti-inflammatory medications, as outlined in the 2019 EULAR recommendations for the management of SLE 1.

Management

The management of lupus-like syndrome involves:

  • Removing the underlying cause, such as discontinuing the triggering medication
  • Using anti-inflammatory medications like NSAIDs, antimalarials such as hydroxychloroquine 1, or corticosteroids depending on severity
  • Monitoring for and managing potential co-morbidities, such as cardiovascular disease and osteoporosis, as recommended by the 2008 EULAR guidelines 1

From the FDA Drug Label

A lupus erythematosus-like syndrome of arthralgia, pleural or abdominal pain, and sometimes arthritis, pleural effusion, pericarditis, fever, chills, myalgia, and possibly related hematologic or skin lesions The symptoms of lupus-like syndrome include:

  • Arthralgia
  • Pleural or abdominal pain
  • Arthritis
  • Pleural effusion
  • Pericarditis
  • Fever
  • Chills
  • Myalgia
  • Hematologic lesions
  • Skin lesions 2

From the Research

Symptoms of Lupus-like Syndrome

The symptoms of lupus-like syndrome, also known as drug-induced lupus erythematosus (DILE), can vary depending on the drug causing the condition. Some common symptoms include:

  • Musculoskeletal symptoms, such as arthritis in the hands and wrists 3
  • Skin signs, such as rashes 4
  • Systemic involvement, such as fever, fatigue, and weight loss 5
  • Positive antinuclear antibody (ANA) titers and positive LE cell preparations 5, 3
  • Pancytopenia, a condition characterized by a decrease in all blood cell types 6
  • Serositis, or inflammation of the lining surrounding the lungs, heart, or abdomen 4
  • Cytopenia, a condition characterized by a decrease in one or more blood cell types 4

Laboratory Abnormalities

Laboratory abnormalities associated with lupus-like syndrome include:

  • Elevated erythrocyte sedimentation rate (ESR) 3
  • Positive anti-histone antibodies 4, 6
  • Positive anti-double strand (ds) DNA antibodies, although this is rare in DILE 4
  • Low serum complement levels, which are rarely present in classic DILE but more common in anti-TNFalpha DILE 4

Drug-Induced Lupus Erythematosus

DILE can be caused by a variety of drugs, including:

  • Hydralazine 5, 4, 6, 3, 7
  • Procainamide 5, 4, 3, 7
  • Isoniazid 5, 4, 7
  • Anti-TNFalpha agents, which can cause a distinct form of DILE with different clinical features and laboratory abnormalities 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Drug-induced systemic lupus erythematosus.

Clinical pharmacy, 1985

Research

Drug-induced lupus erythematosus.

Archives of dermatological research, 2009

Research

A systemic lupus erythematosus-like syndrome induced by procainamide.

Clinical orthopaedics and related research, 1978

Research

Drug-induced immune-complex disease.

Complement and inflammation, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.